首页> 外文期刊>Stem cell reviews and Reports >Convenient and efficient enrichment of the CD133+ liver cells from rat fetal liver cells as a source of liver stem/progenitor cells.
【24h】

Convenient and efficient enrichment of the CD133+ liver cells from rat fetal liver cells as a source of liver stem/progenitor cells.

机译:从大鼠胎儿肝细胞中便捷高效地富集CD133 +肝细胞,作为肝干/祖细胞的来源。

获取原文
获取原文并翻译 | 示例
           

摘要

Although the stem cells are commonly isolated by FACS or MACS, they are very expensive and these is no specific marker for liver stem/progentior cells (LSPCs). This paper applied a convenient and efficient method to enrich LSPCs. The fetal liver cells (FLCs) were firstly enriched by Percoll discontinuous gradient centrifugation (PDGC) from the rat fetal liver. Then the FLCs in culture were purified to be homogeneous in size by differential trypsinization and differential adherence (DTDA). Flow cytometric analysis revealed more than half of the purified FLCs expressed alternative markers of LSPCs (CD117, c-Met, Sca-1, CD90, CD49f and CD133). In other words, the purified FLCs were heterogeneous. Therefore, they were sequentially layered into six fractions by Percoll continuous gradient centrifugation (PCGC). Both CD133 and CD49f expressed decreasingly from fraction 1 to 6. In fraction 1 and 2, about 85% FLCs expressed CD133, which were revealed to be LSPCs by high expressions of AFP and CK-19, low expressions of G-6-P and ALB. To conclude, the purity of CD133(+) LSPCs enriched by combination of PDGC, DTDA and PCGC is close to that obtained by MACS. This study will greatly contribute to two important biological aspects: liver stem cells isolation and liver cell therapy.
机译:尽管干细胞通常是通过FACS或MACS分离的,但它们非常昂贵,并且它们不是肝干/祖细胞(LSPC)的特异性标记。本文应用了一种方便有效的方法来丰富LSPC。首先通过大鼠胎肝的Percoll不连续梯度离心(PDGC)富集胎肝细胞(FLC)。然后,通过差异胰蛋白酶消化和差异粘附(DTDA)将培养物中的FLC纯化至均一大小。流式细胞仪分析显示,超过一半的纯化FLC表达了LSPC的替代标记(CD117,c-Met,Sca-1,CD90,CD49f和CD133)。换句话说,纯化的FLC是异质的。因此,通过Percoll连续梯度离心(PCGC)将它们依次分层为六个部分。 CD133和CD49f的表达都从级分1到级6降低。在级分1和2中,大约85%的FLC表达CD133,高表达的AFP和CK-19,低表达的G-6-P和高表达表明它们是LSPC。 ALB。总而言之,通过PDGC,DTDA和PCGC的组合富集的CD133(+)LSPC的纯度接近于MACS获得的纯度。这项研究将极大地促进两个重要的生物学方面:肝干细胞分离和肝细胞治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号